Peptides 101 for Women
What Are Peptides? A Women's Guide to Therapeutic Peptides
Peptides are short chains of amino acids — the same building blocks your body uses to make hormones, repair tissue, and signal between cells. In medicine, 'peptide therapy' means using specific, lab-made versions of those signaling molecules to support healing, metabolism, sleep, skin, or hormone balance. Here's what they actually are, what the science says for women in perimenopause and beyond, and what's legal in the U.S. right now.
The simple definition
A peptide is a short chain of amino acids — typically between 2 and 50 — linked together. Proteins are long chains (often hundreds of amino acids); peptides are the smaller fragments. Your body makes thousands of them every day. Insulin is a peptide. Oxytocin is a peptide. Glucagon is a peptide. So is the GLP-1 that semaglutide mimics.
In a clinical setting, "peptide therapy" refers to giving a specific, lab-synthesized peptide as a medication — usually by subcutaneous injection — to amplify or replace a natural signal your body is producing too little of, or to trigger a healing or metabolic response.
How peptides actually work in the body
Peptides are signaling molecules. They bind to receptors on the surface of your cells and tell those cells to do something specific — release growth hormone, lower blood sugar, reduce inflammation, repair tissue, slow gastric emptying. They are not hormones in the steroid sense (estrogen, progesterone, testosterone are steroid hormones built from cholesterol). Peptides act more like text messages between systems.
Because they are short and broken down quickly by digestion, most therapeutic peptides cannot be taken as a pill. They are given by subcutaneous injection, nasal spray, or troche — formats that bypass the gut.
Why women in perimenopause and menopause are paying attention
Between roughly age 40 and 60, several systems decline together: growth hormone, estrogen, sleep quality, muscle mass, skin collagen, gut barrier function, and metabolic flexibility. That overlap is why peptide therapy has become part of the modern menopause conversation — not as a replacement for hormone therapy, but as an adjunct for symptoms that HRT alone does not fully address (visceral fat, recovery, sleep architecture, skin elasticity).
It is worth saying clearly: hormone replacement therapy is the most evidence-backed treatment for menopausal symptoms. Peptides are complementary, not a substitute.
The peptides women ask about most
GLP-1 agonists — semaglutide and tirzepatide
These are the most studied, most prescribed, and most fully FDA-approved peptides in medicine. They mimic GLP-1, a gut peptide that regulates appetite and insulin. In women with menopausal weight gain — particularly visceral fat — they are the most effective non-surgical option currently available. See the full GLP-1 guide →
Sermorelin and tesamorelin (GHRH analogs)
These stimulate your pituitary to make its own growth hormone in a natural, pulsatile pattern. Used clinically for sleep quality, body composition, and visceral fat reduction. Tesamorelin is FDA-approved for HIV-associated lipodystrophy and used off-label for menopausal visceral fat. Sermorelin remains available through 503A compounding.
CJC-1295 and ipamorelin
Two growth-hormone-releasing peptides typically combined. Popular in longevity clinics for sleep, recovery, and lean mass. Currently restricted from compounding pending the July 2026 FDA review.
BPC-157
A 15-amino-acid peptide originally isolated from human gastric juice, studied for gut healing and tissue repair. Strong preclinical (animal) evidence, limited human trials. Currently on the FDA do-not-compound list. Read the legal status briefing →
PT-141 (bremelanotide)
FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. A melanocortin peptide that acts on the central nervous system rather than the vascular system.
Thymosin alpha-1
An immune-modulating peptide studied in chronic viral illness and immune dysregulation. Available through 503A compounding under physician supervision.
What peptides cannot do
Peptides will not replace lost ovarian estrogen. They will not reverse osteoporosis on their own. They will not "biohack" you past the underlying biology of menopause. They are tools — sometimes powerful ones, sometimes modest ones — that work best inside a real clinical plan that also addresses sleep, strength training, protein intake, and where appropriate, hormone therapy.
What "legal" actually means in 2026
Three categories matter:
- FDA-approved drug products — semaglutide, tirzepatide, tesamorelin, bremelanotide. Manufactured and sold under brand names; prescribed like any other medication.
- Compounded by 503A pharmacies — sermorelin, ipamorelin (status pending), thymosin alpha-1, PT-141 compounded versions. Legally prepared under a physician's prescription for a specific patient. Not FDA-approved as drug products.
- Currently restricted — BPC-157, CJC-1295 (under July 2026 PCAC review), and several others. Not legally available through licensed U.S. pharmacies right now.
Products sold online as "research peptides" fall outside all three categories and are not legal for human use.
How kindr evaluates peptides
kindr's physicians evaluate peptide therapy only as part of a supervised longevity or menopause plan, after labs and a full history. We prescribe only what is currently legal under FDA and state-board rules. We do not source from research-chemical suppliers, and we use FDA-registered 503A compounding pharmacies for compounded peptides.
Where to go next
Frequently asked questions
Are peptides the same as steroids?
No. Steroids are lipid (fat-based) hormones like testosterone or estrogen. Peptides are short protein fragments that act as signals — they tell your existing systems (growth hormone axis, immune cells, gut lining) to do something. Most therapeutic peptides do not bind to androgen or estrogen receptors at all.
Are peptides safe for women in perimenopause or menopause?
Many peptides have decades of safety data in clinical use (semaglutide, tesamorelin, sermorelin). Others — BPC-157, CJC-1295, ipamorelin — are under FDA review in July 2026 and are not currently compoundable. Safety depends on the specific peptide, your medical history, and whether it is prescribed and monitored by a licensed clinician. kindr only evaluates peptides as part of supervised care.
Do peptides cause weight loss?
Some do, directly. GLP-1 receptor agonists like semaglutide and tirzepatide are peptides — they are the most studied weight-loss medications in modern medicine. Other peptides (AOD-9604, tesamorelin) target visceral fat with smaller effects. Growth-hormone-releasing peptides like CJC-1295/ipamorelin are not weight-loss drugs.
Can I buy peptides online?
Products sold online "for research use only" are not legal for human use in the U.S. and have no quality verification. Legitimate therapeutic peptides require a prescription and are dispensed by FDA-registered 503A compounding pharmacies under physician supervision.
Are peptides FDA-approved?
Some are fully FDA-approved drugs (semaglutide/Ozempic/Wegovy, tirzepatide/Mounjaro/Zepbound, tesamorelin/Egrifta). Others are prepared by 503A compounding pharmacies under physician prescription, which is a separate, legal pathway — not the same as FDA approval. A handful (BPC-157, CJC-1295) are currently restricted from compounding pending the July 2026 FDA review.
Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.
Request your Longevity Consult →Related: FDA peptide review July 2026 briefing · Peptide therapy hub · Longevity service
Medically reviewed by Dr. Ana Lisa Carr, MD, MBA · Last reviewed 2026-06-22. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.